Stockreport

India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US [Read more]